                         SEQUENCE LISTING

<110>  Yoo, Stephen S
 
<120>  ANTIBODIES SPECIFIC TO GLYCOSYLATED CTLA-4 AND METHODS OF USE 
       THEREOF

<130>  24258.0013P1

<150>  62/906,500
<151>  2019-09-26

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  223
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Ala Cys Leu Gly Phe Gln Arg His Lys Ala Gln Leu Asn Leu Ala 
1               5                   10                  15      


Thr Arg Thr Trp Pro Cys Thr Leu Leu Phe Phe Leu Leu Phe Ile Pro 
            20                  25                  30          


Val Phe Cys Lys Ala Met His Val Ala Gln Pro Ala Val Val Leu Ala 
        35                  40                  45              


Ser Ser Arg Gly Ile Ala Ser Phe Val Cys Glu Tyr Ala Ser Pro Gly 
    50                  55                  60                  


Lys Ala Thr Glu Val Arg Val Thr Val Leu Arg Gln Ala Asp Ser Gln 
65                  70                  75                  80  


Val Thr Glu Val Cys Ala Ala Thr Tyr Met Met Gly Asn Glu Leu Thr 
                85                  90                  95      


Phe Leu Asp Asp Ser Ile Cys Thr Gly Thr Ser Ser Gly Asn Gln Val 
            100                 105                 110         


Asn Leu Thr Ile Gln Gly Leu Arg Ala Met Asp Thr Gly Leu Tyr Ile 
        115                 120                 125             


Cys Lys Val Glu Leu Met Tyr Pro Pro Pro Tyr Tyr Leu Gly Ile Gly 
    130                 135                 140                 


Asn Gly Thr Gln Ile Tyr Val Ile Asp Pro Glu Pro Cys Pro Asp Ser 
145                 150                 155                 160 


Asp Phe Leu Leu Trp Ile Leu Ala Ala Val Ser Ser Gly Leu Phe Phe 
                165                 170                 175     


Tyr Ser Phe Leu Leu Thr Ala Val Ser Leu Ser Lys Met Leu Lys Lys 
            180                 185                 190         


Arg Ser Pro Leu Thr Thr Gly Val Tyr Val Lys Met Pro Pro Thr Glu 
        195                 200                 205             


Pro Glu Cys Glu Lys Gln Phe Gln Pro Tyr Phe Ile Pro Ile Asn 
    210                 215                 220             


<210>  2
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic construct; MAb STC1807 mature heavy chain V domain

<400>  2
gaggttcagc tgcagcagtc tggggctgag cttgtgaggc caggggcctt agtcaagttg       60

tcctgcaaag cttctggctt caacattaaa gactactata tgaactgggt gaaacagagg      120

cctgaacagg gcctggagtg gattggatgg attgatcctg agaatggtaa tactatatat      180

gacccgaagt tccagggcaa ggccagtata atagcagaca catcctccaa cacagcctac      240

ctgcagctca gcagcctgac atctgaggac actgccgtct attactgtgc tagaaaatgg      300

tcctatacta tggactactg gggtcaaggc acctcagtca ccgtctcctc a               351


<210>  3
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; MAb STC1807 mature heavy chain V domain

<400>  3

Glu Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Ala 
1               5                   10                  15      


Leu Val Lys Leu Ser Cys Lys Ala Ser Gly Phe Asn Ile Lys Asp Tyr 
            20                  25                  30          


Tyr Met Asn Trp Val Lys Gln Arg Pro Glu Gln Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Asp Pro Glu Asn Gly Asn Thr Ile Tyr Asp Pro Lys Phe 
    50                  55                  60                  


Gln Gly Lys Ala Ser Ile Ile Ala Asp Thr Ser Ser Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Leu Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Lys Trp Ser Tyr Thr Met Asp Tyr Trp Gly Gln Gly Thr Ser 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  4
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic construct; MAb STC1807 light chain V domain

<400>  4
caaattgttc tcacccagtc tccagcactc atgtctgcat ctccagggga gaaggtcacc       60

atgacctgca gtgccagctc atttgtaggt tacatgtact ggtaccagca gaagccaaga      120

tcctccccca aaccctggat ttatctcaca tccaacctgg cttctggagt ccctggtcgc      180

ttcagtggca gtgggtctgg gacctcttac tctctcacaa tcagcaacat ggaggctgaa      240

gatgctgcca cttattactg ccagcagtgg agtagtaacc cgctcacgtt cggtgctggg      300

accaagctgg aactgaaa                                                    318


<210>  5
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; MAb STC1807 light chain V domain

<400>  5

Gln Ile Val Leu Thr Gln Ser Pro Ala Leu Met Ser Ala Ser Pro Gly 
1               5                   10                  15      


Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Phe Val Gly Tyr Met 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Arg Ser Ser Pro Lys Pro Trp Ile Tyr 
        35                  40                  45              


Leu Thr Ser Asn Leu Ala Ser Gly Val Pro Gly Arg Phe Ser Gly Ser 
    50                  55                  60                  


Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Asn Met Glu Ala Glu 
65                  70                  75                  80  


Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Leu Thr 
                85                  90                  95      


Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys 
            100                 105     


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR1

<400>  6

Gly Phe Asn Ile Lys Asp Tyr 
1               5           


<210>  7
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR2

<400>  7

Asp Pro Glu Asn Gly Asn 
1               5       


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR3

<400>  8

Lys Trp Ser Tyr Thr Met Asp Tyr 
1               5               


<210>  9
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR1

<400>  9

Gly Phe Asn Ile Lys Asp Tyr Tyr Met Asn 
1               5                   10  


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR2

<400>  10

Trp Ile Asp Pro Glu Asn Gly Asn Thr Ile 
1               5                   10  


<210>  11
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR1

<400>  11

Lys Trp Ser Tyr Thr Met Asp Tyr 
1               5               


<210>  12
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR2

<400>  12

Trp Ile Asp Pro Glu Asn Gly Asn Thr Ile Tyr Asp Pro Lys Phe Gln 
1               5                   10                  15      


Gly Gly 
        


<210>  13
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR1

<400>  13

Lys Asp Tyr Tyr Met Asn 
1               5       


<210>  14
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR2

<400>  14

Trp Ile Gly Trp Ile Asp Pro Glu Asn Gly Asn Thr Ile Tyr 
1               5                   10                  


<210>  15
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR3

<400>  15

Ala Arg Lys Trp Ser Tyr Thr Met Asp 
1               5                   


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR1

<400>  16

Ser Ala Ser Ser Phe Val Gly Tyr Met Tyr 
1               5                   10  


<210>  17
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR2

<400>  17

Leu Thr Ser Asn Leu Ala Ser 
1               5           


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR3

<400>  18

Gln Gln Trp Ser Ser Asn Pro Leu Thr 
1               5                   


<210>  19
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR1

<400>  19

Gly Tyr Met Tyr Trp Tyr 
1               5       


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR2

<400>  20

Pro Trp Ile Tyr Leu Thr Ser Asn Leu Ala 
1               5                   10  


<210>  21
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; STC1807 Heavy chain CDR3

<400>  21

Gln Gln Trp Ser Ser Asn Pro Leu 
1               5               


<210>  22
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; HA tag

<400>  22

Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
1               5                   


